Technology | Lung Imaging | October 05, 2018

Platform creates augmented reality to see fluoroscopically invisible lung lesions

Body Vision Medical Announces Release of LungVision

October 5, 2018 — Body Vision Medical, a medical device company specializing in lung cancer diagnostics, announced the launch of its LungVision platform. The platform will be presented at the CHEST conference, Oct. 7-10 in San Antonio, Texas.

"Body Vision provides a great tool that has changed the way we approached peripheral nodules. Its unique technology creates augmented reality with the ability to see fluoroscopically invisible lesions and the pathways under the live fluoro, while tracking a patient breathing," said D. Kyle Hogarth, M.D., FCCP, president of the Society for Advanced Bronchoscopy, associate professor of medicine, director of bronchoscopy at the University of Chicago. "Once the technology has guided us to the lesion, we confirm the lesion's relationship to the airway with radial-EBUS [endobronchial ultrasound]. We then use our off-the-shelf biopsy instruments via the LungVision catheter. The augmented fluoro image, integrated with the radial EBUS images, allows us to obtain tissue samples with continuous real-time confirmation of location. The beauty of it all is how simple and elegant the technology is."

Body Vision CEO Dorian Averbuch said the product targets small pulmonary nodules that, if diagnosed early, can be resected to cure lung cancer. The technology provides step-by-step guidance through planning, navigation and lesion localization during biopsy.

The clinical experience with the LungVision platform will be featured through the following panel presentations during the CHEST conference at San Antonio, TX:

  • Sun. Oct. 7
    • Krish Bhadra, M.D., Novel Augmented Fluoroscopic Imaging Platform Accuracy Assessment during Navigation Bronchoscopy in Simultaneous Comparison with Cone Beam CT and Radial EBUS
    • D. Kyle Hogarth, M.D., FCCP, A Novel Endobrachial Fluoroscopic Navigation and Localization System: a summary of a multi-center LungVision Trial
  • Tue., Oct. 9
    • Patrick E. Whitten, M.D., FCCP, Augmented Endobronchial Fluoroscopic Navigation and Localization System: Integration of Multimodalities and Biopsy Tools to Increase Diagnostic Yield

For more information: www.bodyvisionmedical.com


Related Content

News | FDA

February 12, 2024 — Proscia, a leading provider of digital and computational pathology solutions, has received 510(k) ...

Time February 12, 2024
arrow
News | Artificial Intelligence

February 1, 2024 — Nearly 8,000 veterans are diagnosed with lung cancer each year. Now at-risk veterans will have access ...

Time February 01, 2024
arrow
News | Artificial Intelligence

January 22, 2024 — Thirona, a global company specializing in advanced analysis of thoracic CT images with artificial ...

Time January 22, 2024
arrow
Feature | Artificial Intelligence

Coherent Market Insights has recently published a report, titled, Artificial Intelligence in Oncology Market, By ...

Time January 12, 2024
arrow
News | Artificial Intelligence

January 8, 2024 — Qure.ai, a leading global innovator in medical imaging solutions, has announced its 13th FDA clearance ...

Time January 08, 2024
arrow
News | Radiology Business

December 27, 2023 — The American Roentgen Ray Society (ARRS) announced David M. Naeger, MD, as the 2024 ARRS ...

Time December 27, 2023
arrow
News | Radiology Business

December 13, 2023 — The global medical technology company 4DMedical has announced it has entered a binding agreement to ...

Time December 13, 2023
arrow
News | Computed Tomography (CT)

November 28, 2023 — Smoking marijuana in combination with cigarettes may lead to increased damage of the lung’s air sacs ...

Time November 28, 2023
arrow
News | RSNA

November 25, 2023 — 4DMedical, a global technology company and producer of advanced lung function imaging software, has ...

Time November 24, 2023
arrow
News | Computed Tomography (CT)

November 22, 2023 — Lung cancer is one of the world’s silent killers. By the time patients experience symptoms, the ...

Time November 22, 2023
arrow
Subscribe Now